We can buy this stock at 1,17$, Aclaris Therapeutics Inc, with address at 640 LEE ROAD SUITE 200, WAYNE, Pennsylvania, 19087, United States, is a publicly traded company and its visible heads at the moment are David Gordon (Chief Medical Officer), Frank Ruffo (Chief Financial Officer & Treasurer), Joseph B. Monahan (Chief Scientific Officer), Neal S. Walker (President, Chief Executive Officer & Director). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 1,15$ - 1,19$, with a percentage difference of 1,17$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].